BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37272953)

  • 1. Multimodal treatment and immune checkpoint inhibition in sinonasal mucosal melanoma: real-world data of a retrospective, single-center study.
    Scherzad A; Stöth M; Meyer TJ; Haug L; Gehrke T; Schilling B; Meierjohann S; Scheich M; Hagen R; Gesierich A; Hackenberg S
    Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4215-4223. PubMed ID: 37272953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy.
    Rose AAN; Armstrong SM; Hogg D; Butler MO; Saibil SD; Arteaga DP; Pimentel Muniz T; Kelly D; Ghazarian D; King I; Kamil ZS; Ross K; Spreafico A
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33483342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy in the Management of Sinonasal Mucosal Melanoma: A Systematic Review.
    Tang A; Taori S; Dang S; Gardner PA; Zenonos GA; Davar D; Kuan EC; Snyderman CH; Wang EW; Choby G
    Otolaryngol Head Neck Surg; 2024 Apr; ():. PubMed ID: 38686598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinonasal mucosal melanoma: treatment strategies and survival rates for a rare disease entity : A single center experience and review of literature.
    Andrianakis A; Kiss P; Pomberger M; Wolf A; Thurnher D; Tomazic PV
    Wien Klin Wochenschr; 2021 Nov; 133(21-22):1137-1147. PubMed ID: 33844113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal and distant metastases in sinonasal mucosal melanoma: A population-based analysis.
    Low CM; Price DL; Moore EJ; Stokken JK; Van Abel KM; Janus JR; Choby G
    Laryngoscope; 2020 Mar; 130(3):622-627. PubMed ID: 31077407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinonasal Mucosal Melanoma: Role of Tumor Proliferative Indices and Pathological Factors in Survival.
    Guo R; Jenkins SM; Johnson BJ; Reed K; Kroneman T; Choby G
    Laryngoscope; 2022 Dec; 132(12):2350-2358. PubMed ID: 35661370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary mucosal malignant melanoma of the head and neck.
    Patel SG; Prasad ML; Escrig M; Singh B; Shaha AR; Kraus DH; Boyle JO; Huvos AG; Busam K; Shah JP
    Head Neck; 2002 Mar; 24(3):247-57. PubMed ID: 11891956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma.
    Amit M; Na'ara S; Hanna EY
    Curr Oncol Rep; 2018 Feb; 20(2):10. PubMed ID: 29492677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Margin Status and Survival Following Resection of Sinonasal Mucosal Melanoma.
    Elsamna ST; Ahsanuddin S; Mir GS; Sukyte-Raube D; Fang CH; Baredes S; Eloy JA
    Laryngoscope; 2021 Nov; 131(11):2429-2435. PubMed ID: 33864635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in advanced sinonasal mucosal melanoma: a single institution experience.
    Meerwein CM; Hüllner M; Braun R; Soyka MB; Morand GB; Holzmann D
    Eur Arch Otorhinolaryngol; 2019 Aug; 276(8):2259-2265. PubMed ID: 31098872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adjuvant therapy on survival for sinonasal mucosal melanoma.
    Lai Y; Meng X; Liu Q; Lu H; Guo L; Wang S; Wang D
    Acta Otolaryngol; 2020 Jan; 140(1):79-84. PubMed ID: 31755795
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
    Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
    Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases.
    Zebary A; Jangard M; Omholt K; Ragnarsson-Olding B; Hansson J
    Br J Cancer; 2013 Aug; 109(3):559-64. PubMed ID: 23860532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
    Amit M; Tam S; Abdelmeguid AS; Kupferman ME; Su SY; Raza SM; DeMonte F; Hanna EY
    Ann Surg Oncol; 2018 Jun; 25(6):1723-1729. PubMed ID: 29626308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A multicentre retrospective analysis.
    Versluis JM; Hendriks AM; Weppler AM; Brown LJ; de Joode K; Suijkerbuijk KPM; Zimmer L; Kapiteijn EW; Allayous C; Johnson DB; Hepner A; Mangana J; Bhave P; Jansen YJL; Trojaniello C; Atkinson V; Storey L; Lorigan P; Ascierto PA; Neyns B; Haydon A; Menzies AM; Long GV; Lebbe C; van der Veldt AAM; Carlino MS; Sandhu S; van Tinteren H; de Vries EGE; Blank CU; Jalving M
    Eur J Cancer; 2021 Jul; 151():72-83. PubMed ID: 33971447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases.
    Kowalski ES; Remick JS; Sun K; Alexander GS; Khairnar R; Morse E; Cherng HR; Berg LJ; Poirier Y; Lamichhane N; Becker S; Chen S; Molitoris JK; Kwok Y; Regine WF; Mishra MV
    Radiat Oncol; 2020 Oct; 15(1):245. PubMed ID: 33109224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases.
    Hilbers ML; Dimitriou F; Lau P; Bhave P; McArthur GA; Zimmer L; Kudura K; Gérard CL; Levesque MP; Michielin O; Dummer R; Cheng PF; Mangana J
    Eur J Cancer; 2021 Oct; 156():149-163. PubMed ID: 34454317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition.
    Le A; Mohammadi H; Mohammed T; Burney H; Zang Y; Frye D; Shiue K; Lautenschlaeger T; Miller J
    J Neurooncol; 2022 Jul; 158(3):481-488. PubMed ID: 35641840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study.
    Vanaken L; Woei-A-Jin FJSH; Van Ginderdeuren R; Deroose CM; Laenen A; Missotten G; Thal DR; Bechter O; Schöffski P; Clement P
    Acta Oncol; 2023 May; 62(5):480-487. PubMed ID: 37200223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and therapy of sinonasal mucosal melanoma].
    Stöth M; Scheich M; Hackenberg S; Scherzad A
    Laryngorhinootologie; 2024 Jan; 103(1):59-69. PubMed ID: 38181776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.